Market Currents
ISTA Pharmaceuticals (ISTA) announces that it landed a U.S. patent allowance for Prolensa along...
-
Friday, January 6, 2012, 8:03 AM ETISTA Pharmaceuticals (ISTA) announces that it landed a U.S. patent allowance for Prolensa along with partner Senju Pharmaceuticals. The firm says it anticipates filing a New Drug Application with the FDA for Prolensa in H1, with a commercial launch expected in early 2013.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
